Mayne Pharma Group
MYX.AX
#7192
Rank
HK$2.84 B
Marketcap
HK$34.96
Share price
0.86%
Change (1 day)
4.55%
Change (1 year)

P/E ratio for Mayne Pharma Group (MYX.AX)

P/E ratio at the end of 2024: -1.90

According to Mayne Pharma Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.0728. At the end of 2024 the company had a P/E ratio of -1.90.

P/E ratio history for Mayne Pharma Group from 2007 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2024-1.90-168.56%
20232.77-291.8%
2022-1.44-27.32%
2021-1.99-63.64%
2020-5.47136.5%
2019-2.31-69.98%
2018-7.70-154.41%
201714.2-40.4%
201623.7-62.69%
201563.6336.99%
201414.6-135.69%
2013-40.8-905.81%
20125.06-80.19%
201125.676.8%
201014.5-579.65%
2009-3.01-42.27%
2008-5.22-49.3%
2007-10.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.